-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Adaptive Biotechnologies Corp quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2018 to Q2 2024.
- Adaptive Biotechnologies Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $20.3M, a 14.9% decline year-over-year.
- Adaptive Biotechnologies Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $85M, a 6.98% decline year-over-year.
- Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2023 was $88.6M, a 7.35% decline from 2022.
- Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2022 was $95.6M, a 0.15% increase from 2021.
- Adaptive Biotechnologies Corp annual Selling and Marketing Expense for 2021 was $95.5M, a 55.6% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)